The course of metastatic prostate cancer under treatment


Demir A., Cecen K., Karadag M. A. , Kocaaslan R., Turkeri L.

SPRINGERPLUS, cilt.3, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

The first-line management of metastatic prostate cancer is hormonal therapy. However, resistance to this treatment will emerge within an average of 24 months. Our purpose was to determine the course of metastatic prostate cancer under treatment.